Friday, July 5, 2013

Something is strange. 25 : Whose is the patent? 4


Professor Yamanaka has a Nobel Prize based on the iPS cell research 



< Professor Yamanaka has a Nobel Prize based on the iPS cell research >

This time article becomes a summary.

Is what in the background?

Even though the number of patent applications in Japan is world leading, there are few epoch-making things.
A reason for increasing the numbers is based on a patent application method.
Inventions in Japan are superior by the improvement of technique and product, but there are few things that introduced launching of new industries.

Though an epoch-making iPS cell research arose domestically, many Japan’s brains often succeeds still only in the United States
This difference is a problem.

Moreover, the government is positive to liberalization of the employment dismissal from company.
The method is just opposite although I can understand the necessity for worker transfer from declining industry or company.
Making of groundwork in that workers and engineers (implementer or researcher) can aim at the new world are necessary.
Excellent retired engineers are pulled out to foreign countries, and cause a technological outflow frequently.

As for the U.S. where new industry occurs frequently, and Germany where economy is strong, patent right is granted to employees.
If you know the details, please teach me.




まとめになります。

背景にあるもの
日本は出願件数こそ世界有数ですが、画期的なものは少ない。
数が多いのは特許の出願方式によるものです。
技術や製品の改善や応用で優れるが、産業を興すものは少ない。
画期的なiPS細胞研究が国内で生まれたが、やはり日本の頭脳はアメリカでこそ成功する場合が多い。
この違いが問題です。

また政府は企業による従業員解雇の自由化に積極的です。
衰退産業や企業からの労働者転出の必要性は理解出来るが、方法が真逆です。
労働者、とりわけ技術者(開発・研究)が新天地を目指せるような下地作りが必要です。
退職した優秀な技術者は、海外に引き抜かれ、技術流出を頻発させるだけです。

新規産業が頻出する米国、経済が強いドイツは、従業員に特許権が与えられている。(詳細を知っている方は教えて下さい)


Many gene analyses machines were put on a private laboratory of China

< Many gene analyses machines were put on a private laboratory of China

On the other hand, some people might have a sense of discomfort by dealing preferentially with employee invention.
A present invention might spend a large amount of expense and time by cooperation.
Moreover, even if the patent can be approved, the patents to contribute to the profit of the company greatly are only handful.
Naturally, in a company, the income of the result of the invention and outgo of a large amount of research cost must balance.

Therefore, it will not be said that a lot of inventions are ability or past results of one person.

On the other hand, the salesman and the manager have a favor of the performance evaluation etc.
The copyright also protects individual rights.



一方、職務発明が優遇されることに違和感を持たれるかもしれません。
現在の発明は、共同による多額の費用と時間をかけて行うことがあります。
また特許が取れても、会社の利益に大きく貢献するものは、ほんの一握りです。
当然、企業は発明の成果と多額の研究費との収支が釣り合わなければなりません。
したがって多くの発明は一人の能力や実績によるものとは言えないでしょう。

一方、営業マンや経営・管理者は業績評価などの恩恵があります。
著作権なども個人の権利を保護しています。


Let's change a view for a bit.
In work ethic of Japan, there is a tendency to disregard a talent of individual and an inspiration, because the people lay weight on the effort of individual and the appeasement of the office.
After all, Japanese society as a whole is regarding the evaluation of invention as low.
It is a cause of stagnating the employee invention.


少し見方を変えてみましょう
日本の労働観では、努力と職場の宥和に重きを置くあまり、個人の才能やひらめきを軽視する傾向にあります。
結局、社会全体が発明への評価を低く見ているのです。
このことが、回りまわって職務発明を停滞させている一因なのです。


Yamanaka professor's laboratory 

< Yamanaka professor's laboratory >
At the end, summary
For the revitalization of Japanese economy, a new technology and industry that provides competitiveness have to be produced.
For that, it is necessary to rouse the desire for the invention and the entrepreneurship.
Therefore, it is necessary to distribute the result of patent to the employee and the individual.
The important is not only a superficial policy (monetary policy), has to be a conversion that gives birth to revitalization and the reformation.



最後に、まとめます。
日本経済の活性には、競争力のある新しい技術と産業を生みだすことです。
そのためには発明や起業への意欲を喚起すべきです。
特許の成果を従業員や個人に分与することは、その為に必要です。
重要なことは、小手先(金融政策)だけでなく、活性や革新を生む転換なのです。





No comments:

Post a Comment